Investigators recently published findings from a prospective, multicenter trial assessing a new targeted biologic therapy for moderate-to-severe Crohn's disease. Over a 5-year observation period, the primary outcome measured was the requirement for surgical bowel resection. Data showed that 28% of individuals in the control arm (receiving standard care plus placebo) required surgical intervention. In contrast, researchers noted that the addition of the new biologic yielded a 25% relative risk reduction (RRR) for this primary outcome. The authors specified the 95% confidence interval (CI) for the RRR as 12% to 38%. Utilizing these reported parameters, which of the following correctly identifies the number needed to treat (NNT) to prevent one surgical resection over the 5-year period, along with the correct 95% CI for the relative risk (RR)?
- NNT = 15; 95% CI for RR = 0.62 to 0.88Cevap
- BNNT = 14; 95% CI for RR = 0.62 to 0.88
- CNNT = 4; 95% CI for RR = 0.62 to 0.88
- DNNT = 34; 95% CI for RR = 0.62 to 0.88
- ENNT = 15; 95% CI for RR = 0.12 to 0.38